Potential molecular marker for detecting transitional cell carcinoma

Urology

Volumn 60, Issue 1, 2002, Pages 181-185

  Chiu, Allen W ^b   Huang, Yu Lun ^a   Huan, Steven K ^a   Wang, Yu Chun ^a   Ju, Jyh Phen ^a   Chen, Mei Fang ^c   Chou, Chen Kung ^b,c  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; HEPATOMA UP REGULATED PROTEIN; MESSENGER RNA; MOLECULAR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER TISSUE; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TRANSITIONAL CELL CARCINOMA; URINALYSIS; URINARY TRACT CARCINOMA;

CARCINOMA, HEPATOCELLULAR; CARCINOMA, TRANSITIONAL CELL; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASM PROTEINS; PROSTATIC HYPERPLASIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0036292269     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01672-2     Document Type: Article

References (17)

1. Urine based markers of urological malignancy
2. Individualizing the approach to invasive bladder cancer
3. Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1
4. Characterization of a novel human cell-cycle-regulated homologue of Drosophila dlg1
5. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder
6. TNM (1978) in bladder cancer: Use and abuse
7. Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors
8. Improved detection of recurrent bladder cancer using the Bard BTA Stat Test
9. Sensitive detection of transitional cell carcinoma of the bladder by microsatellite analysis of cells exfoliated in urine
10. Screening and monitoring for bladder cancer: Refining the use of NMP22
11. Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4
12. Urinary cytokeratin 20 as a marker for transitional cell carcinoma
13. Evaluation of two new urinary tumor markers: Bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder cancer
14. Urinary tissue polypeptide-specific antigen for the diagnosis of bladder cancer
15. Urine detection of survivin and diagnosis of bladder cancer
16. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma
17. Mutation of cell cycle regulators and their impact on superficial bladder cancer